Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$5.11 - $8.76 $1.46 Million - $2.5 Million
285,561 Added 254.09%
397,947 $3.45 Million
Q4 2023

Feb 09, 2024

BUY
$4.7 - $9.87 $528,214 - $1.11 Million
112,386 New
112,386 $736,000
Q2 2023

Aug 11, 2023

BUY
$12.09 - $15.0 $950,503 - $1.18 Million
78,619 Added 443.02%
96,365 $1.2 Million
Q1 2023

May 12, 2023

BUY
$12.99 - $16.48 $230,520 - $292,454
17,746 New
17,746 $248,000
Q2 2022

Aug 12, 2022

SELL
$26.05 - $37.48 $869,314 - $1.25 Million
-33,371 Reduced 78.43%
9,176 $260,000
Q1 2022

May 16, 2022

BUY
$24.46 - $40.92 $1.04 Million - $1.74 Million
42,547 New
42,547 $1.5 Million
Q1 2021

May 17, 2021

SELL
$25.8 - $38.49 $7.88 Million - $11.8 Million
-305,395 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$24.5 - $30.86 $7.48 Million - $9.42 Million
305,395 New
305,395 $8.57 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $1.11B
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.